These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8238696)

  • 1. Medical technology assessment and practice guidelines: their day in court.
    Anderson GF; Hall MA; Steinberg EP
    Am J Public Health; 1993 Nov; 83(11):1635-9. PubMed ID: 8238696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical technology assessment--intended for whom?
    Mariner WK
    Am J Public Health; 1993 Nov; 83(11):1525-6. PubMed ID: 8238670
    [No Abstract]   [Full Text] [Related]  

  • 3. Reimbursing new technologies: why are the courts judging experimental medicine?
    Saver RS
    Stanford Law Rev; 1992 May; 44(5):1095-131. PubMed ID: 10119850
    [No Abstract]   [Full Text] [Related]  

  • 4. Court-ordered reimbursement for unproven medical technology. Circumventing technology assessment.
    Ferguson JH; Dubinsky M; Kirsch PJ
    JAMA; 1993 Apr; 269(16):2116-21. PubMed ID: 8468767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Who should rightfully decide whether a medical treatment necessarily incurred should be excluded from coverage under a health insurance policy provision which excludes from coverage "experimental" medical treatments?
    Fisfis BA
    Duquesne Law Rev; 1993; 31(4):777-800. PubMed ID: 11652669
    [No Abstract]   [Full Text] [Related]  

  • 6. [Jurisdictions on the reimbursement of new medical technologies by public health insurance: A systematic review].
    Ex P; Felgner S; Henschke C
    Z Evid Fortbild Qual Gesundhwes; 2018 Apr; 131-132():8-16. PubMed ID: 29331280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical insurance payments and patients involved in research.
    Holder AR
    IRB; 1994; 16(1-2):19-22. PubMed ID: 11652323
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging technologies and medical coverage.
    Merrikin K; Smith S
    Clin Ethics Rep; 1996; 10(1):9-12. PubMed ID: 11660222
    [No Abstract]   [Full Text] [Related]  

  • 9. Undefined experimental treatment exclusions in health insurance contracts: a proposal for judicial response.
    Belk J
    Wash Law Rev; 1991 Jul; 66(3):809-30. PubMed ID: 11652624
    [No Abstract]   [Full Text] [Related]  

  • 10. When courts review medical appropriateness.
    Anderson G; Hall MA; Smith TR
    Med Care; 1998 Aug; 36(8):1295-302. PubMed ID: 9708600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insurance coverage for experimental technologies.
    Steinberg EP; Tunis S; Shapiro D
    Health Aff (Millwood); 1995; 14(4):143-58. PubMed ID: 8690340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is the method to their "madness?" Experimental treatment exclusions in health insurance policies.
    Lahr JG
    J Contemp Health Law Policy; 1997; 13(2):613-36. PubMed ID: 9212532
    [No Abstract]   [Full Text] [Related]  

  • 13. Prospective self-denial: can consumers contract today to accept health care rationing tomorrow?
    Havighurst CC
    Univ PA Law Rev; 1992 May; 140(5):1755-808. PubMed ID: 11651595
    [No Abstract]   [Full Text] [Related]  

  • 14. Executive summary: value-based purchasing and technology assessment in orthopaedics.
    Ranawat AS; Nunley R; Bozic K
    Clin Orthop Relat Res; 2009 Oct; 467(10):2556-60. PubMed ID: 19495897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The review process used by US health care plans to evaluate new medical technology for coverage.
    Steiner CA; Powe NR; Anderson GF; Das A
    J Gen Intern Med; 1996 May; 11(5):294-302. PubMed ID: 8725978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of technology assessment in health benefits coverage for medical devices.
    Braslow NM; Shatin D; McCarthy DB; Newcomer LN
    Am J Manag Care; 1998 Sep; 4 Spec No():SP139-50. PubMed ID: 10185990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Court-ordered health care.
    Dragalin D
    Courts Health Sci Law; 1991; 1(4):466-70. PubMed ID: 11651233
    [No Abstract]   [Full Text] [Related]  

  • 18. Investigational treatments: coverage, controversy, and consensus.
    Ader M
    Ann Health Law; 1996; (5):45-60. PubMed ID: 10164521
    [No Abstract]   [Full Text] [Related]  

  • 19. The Supreme Court's influence on medicine and health: the Rehnquist Court, 1986-2005.
    Gostin LO
    JAMA; 2005 Oct; 294(13):1685-7. PubMed ID: 16204668
    [No Abstract]   [Full Text] [Related]  

  • 20. Patients as consumers: courts, contracts, and the new medical marketplace.
    Hall MA; Schneider CE
    Mich Law Rev; 2008 Feb; 106(4):643-89. PubMed ID: 18354872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.